エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/01/31 | 6,993 | 7,030 | 6,937 | 6,998 | -21 | -0.3% | 1,498,800 |
| 2024/01/30 | 7,091 | 7,151 | 7,019 | 7,019 | -22 | -0.3% | 1,306,400 |
| 2024/01/29 | 7,011 | 7,090 | 6,994 | 7,041 | +86 | +1.2% | 1,125,500 |
| 2024/01/26 | 6,988 | 7,034 | 6,947 | 6,955 | +4 | +0.1% | 1,026,000 |
| 2024/01/25 | 6,997 | 7,036 | 6,897 | 6,951 | -64 | -0.9% | 1,303,900 |
| 2024/01/24 | 6,993 | 7,038 | 6,961 | 7,015 | +4 | +0.1% | 1,255,000 |
| 2024/01/23 | 7,056 | 7,117 | 6,997 | 7,011 | +2 | ±0% | 1,378,900 |
| 2024/01/22 | 7,000 | 7,039 | 6,971 | 7,009 | -8 | -0.1% | 1,670,200 |
| 2024/01/19 | 7,092 | 7,130 | 6,991 | 7,017 | -63 | -0.9% | 1,959,900 |
| 2024/01/18 | 7,164 | 7,172 | 7,068 | 7,080 | -120 | -1.7% | 1,499,100 |
| 2024/01/17 | 7,400 | 7,428 | 7,190 | 7,200 | -231 | -3.1% | 2,036,200 |
| 2024/01/16 | 7,523 | 7,552 | 7,426 | 7,431 | -103 | -1.4% | 787,200 |
| 2024/01/15 | 7,473 | 7,598 | 7,466 | 7,534 | +55 | +0.7% | 1,008,400 |
| 2024/01/12 | 7,818 | 7,818 | 7,444 | 7,479 | -192 | -2.5% | 2,327,200 |
| 2024/01/11 | 7,585 | 7,691 | 7,583 | 7,671 | +97 | +1.3% | 1,585,100 |
| 2024/01/10 | 7,401 | 7,618 | 7,395 | 7,574 | +309 | +4.3% | 2,753,300 |
| 2024/01/09 | 7,288 | 7,297 | 7,209 | 7,265 | +5 | +0.1% | 1,155,300 |
| 2024/01/05 | 7,193 | 7,322 | 7,193 | 7,260 | +77 | +1.1% | 1,190,300 |
| 2024/01/04 | 7,099 | 7,183 | 7,006 | 7,183 | +131 | +1.9% | 1,179,700 |
| 2023/12/29 | 7,048 | 7,053 | 6,996 | 7,052 | +4 | +0.1% | 832,600 |
| 2023/12/28 | 7,000 | 7,057 | 6,970 | 7,048 | +37 | +0.5% | 787,400 |
| 2023/12/27 | 7,015 | 7,064 | 6,986 | 7,011 | -4 | -0.1% | 1,363,600 |
| 2023/12/26 | 7,002 | 7,043 | 6,997 | 7,015 | +27 | +0.4% | 743,700 |
| 2023/12/25 | 7,040 | 7,060 | 6,985 | 6,988 | +5 | +0.1% | 537,000 |
| 2023/12/22 | 6,965 | 7,033 | 6,961 | 6,983 | +38 | +0.5% | 903,500 |
| 2023/12/21 | 6,971 | 7,003 | 6,863 | 6,945 | -125 | -1.8% | 1,613,000 |
| 2023/12/20 | 7,170 | 7,280 | 7,070 | 7,070 | -36 | -0.5% | 1,513,500 |
| 2023/12/19 | 7,040 | 7,120 | 7,014 | 7,106 | +3 | ±0% | 991,400 |
| 2023/12/18 | 7,150 | 7,179 | 7,096 | 7,103 | -104 | -1.4% | 1,021,100 |
| 2023/12/15 | 7,322 | 7,350 | 7,207 | 7,207 | -169 | -2.3% | 1,745,700 |
| 2023/12/14 | 7,456 | 7,531 | 7,314 | 7,376 | -23 | -0.3% | 1,443,600 |
| 2023/12/13 | 7,513 | 7,619 | 7,394 | 7,399 | -165 | -2.2% | 1,619,300 |
| 2023/12/12 | 7,609 | 7,648 | 7,491 | 7,564 | -5 | -0.1% | 1,544,100 |
| 2023/12/11 | 7,460 | 7,578 | 7,436 | 7,569 | +148 | +2% | 1,137,000 |
| 2023/12/08 | 7,435 | 7,435 | 7,325 | 7,421 | -41 | -0.5% | 1,581,800 |
| 2023/12/07 | 7,555 | 7,578 | 7,445 | 7,462 | -61 | -0.8% | 1,294,300 |
| 2023/12/06 | 7,431 | 7,526 | 7,402 | 7,523 | +97 | +1.3% | 1,503,800 |
| 2023/12/05 | 7,517 | 7,517 | 7,421 | 7,426 | -94 | -1.3% | 1,255,800 |
| 2023/12/04 | 7,629 | 7,631 | 7,452 | 7,520 | -190 | -2.5% | 1,754,200 |
| 2023/12/01 | 7,767 | 7,777 | 7,688 | 7,710 | +38 | +0.5% | 1,041,200 |
| 2023/11/30 | 7,510 | 7,699 | 7,503 | 7,672 | +76 | +1% | 1,523,300 |
| 2023/11/29 | 7,603 | 7,648 | 7,586 | 7,596 | -69 | -0.9% | 635,500 |
| 2023/11/28 | 7,689 | 7,692 | 7,584 | 7,665 | -27 | -0.4% | 1,037,000 |
| 2023/11/27 | 7,820 | 7,826 | 7,674 | 7,692 | -84 | -1.1% | 690,000 |
| 2023/11/24 | 7,770 | 7,832 | 7,762 | 7,776 | +76 | +1% | 831,300 |
| 2023/11/22 | 7,720 | 7,765 | 7,700 | 7,700 | -58 | -0.7% | 787,000 |
| 2023/11/21 | 7,711 | 7,814 | 7,692 | 7,758 | +37 | +0.5% | 879,300 |
| 2023/11/20 | 7,751 | 7,819 | 7,715 | 7,721 | -70 | -0.9% | 745,000 |
| 2023/11/17 | 7,697 | 7,793 | 7,688 | 7,791 | +64 | +0.8% | 733,900 |
| 2023/11/16 | 7,886 | 7,896 | 7,727 | 7,727 | -182 | -2.3% | 1,142,300 |
201～
250
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 464,100円 | +1.7% | -2.9% | 3.45% | 30.45倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 158,400円 | +12.2% | +180.3% | 4.67% | 56.72倍 | 1.86倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 212,200円 | +5.7% | +3.9% | 2.70% | 10.56倍 | 1.40倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 252,400円 | +11.3% | -5.4% | 2.30% | 19.43倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 175,100円 | -3.5% | -50.2% | 4.57% | 14.18倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
